pharmaceuticals
![FAS abolished agreed prices for “Bartizar” medicinal drug](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori-0005868896-bigwww_slider.jpg)
The FAS Russia established that the drug manufacturer submitted false information on the prices of raw materials supplies and set an excessive euro exchange rate in its estimates
more
![FAS position on compiling the list of vital and essential drugs](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/blister.jpg)
The FAS Russia considered a petition of “Johnson & Johnson” Ltd. on the need to re-file a proposal to include medicinal drugs in the list of vital and essential drugs for 2018
more
24.02.2016
FAS proposals on indexing prices for the life-saving and essential medicinal drugs in the lower price segmentmore![FAS proposals on indexing prices for the life-saving and essential medicinal drugs in the lower price segment](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/archive/lori-0000755485-smallwww.jpg)
Due to numerous reports in mass media FAS would like to inform that in November 2015 the Federal Antimonopoly Service (FAS Russia) indeed submitted a proposal to the Government of the Russian Federation to support domestic pharmaceutical manufacturers in the part of one-time indexing of prices for the drugs included in the list of life-saving and essential medicinal drugs with the registered price for up to 50 RUB.
more
12.02.2016
FAS will give approvals for regional mark-ups for life-saving and essential medicines more![FAS will give approvals for regional mark-ups for life-saving and essential medicines](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori-0004865589-bigwww.jpg)
On 1 March 2016 the Federal Antimonopoly Service (FAS Russia) shall be assigned the powers to approve regional maximum wholesale and retail mark-ups to ex-works prices for life-saving and essential medicines. The Prime Minister Dmitry Medvedev signed a relevant Decree (1) on 3 February 2016.
more